University of Kansas

Summary

University of Kansas is a medical facility located in Lawrence, Kansas. This center is recognized for care of Alzheimer's Disease, Obesity, Mild Cognitive Impairment, Autism Spectrum Disorder, Cognitive Impairment and other specialties. University of Kansas is involved with conducting 29 clinical trials across 74 conditions. There are 6 research doctors associated with this hospital, such as Rajesh Pahwa, Joaquina Baranda, MD, Jeffrey Burns, and Brian Boyd, PhD.

Top PIs

Clinical Trials running at University of Kansas

Ovarian Cancer

Breast Cancer

Solid Tumors

Endometrial Cancer

Small Cell Lung Cancer

Pancreatic Cancer

Gastric Cancer

Parkinson's Disease

Breast cancer

Peripheral Nerve Sheath Tumor

NKT3964

for Solid Tumors

The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to determine the preliminary recommended dose for expansion (RDE) of NKT3964 in adults with advanced or metastatic solid tumors. The goal of the Expansion phase of the study is to evaluate the preliminary anti-tumor activity of NKT3964 at the RDEs based on objective response rate (ORR) and determine the preliminary recommended Phase 2 dose (RP2D).

Recruiting

1 award

Phase 1

9 criteria